Table 1.

Changes in leukocyte counts and differential after LPS administration to healthy subjects

Time point (h) Leukocytes Granulocytes MonocytesLymphocytes
−0.5  5.2 ± 1.1  2.9 ± 0.7 0.5 ± 0.1  1.6 ± 0.3  
+0.5  4.9 ± 0.9 2.9 ± 0.7  0.3 ± 0.1  1.5 ± 0.2  
+1 2.0 ± 0.3  0.9 ± 0.3  0.05 ± 0.02 0.9 ± 0.1  
+2  5.2 ± 1.4  4.4 ± 1.4 0.05 ± 0.02  0.7 ± 0.1  
+3  4.9 ± 1.3 4.5 ± 1.3  0.03 ± 0.02  0.4 ± 0.1  
+4 7.8 ± 1.5  7.4 ± 1.4  0.07 ± 0.04 0.3 ± 0.1  
+6  11.1 ± 1.4  10.5 ± 1.4 0.2 ± 0.1  0.4 ± 0.1  
+8  13.0 ± 2.9 12.0 ± 2.9  0.5 ± 0.1  0.5 ± 0.1  
+24 9.7 ± 2.7  7.1 ± 2.6  0.6 ± 0.1 1.7 ± 0.3 
Time point (h) Leukocytes Granulocytes MonocytesLymphocytes
−0.5  5.2 ± 1.1  2.9 ± 0.7 0.5 ± 0.1  1.6 ± 0.3  
+0.5  4.9 ± 0.9 2.9 ± 0.7  0.3 ± 0.1  1.5 ± 0.2  
+1 2.0 ± 0.3  0.9 ± 0.3  0.05 ± 0.02 0.9 ± 0.1  
+2  5.2 ± 1.4  4.4 ± 1.4 0.05 ± 0.02  0.7 ± 0.1  
+3  4.9 ± 1.3 4.5 ± 1.3  0.03 ± 0.02  0.4 ± 0.1  
+4 7.8 ± 1.5  7.4 ± 1.4  0.07 ± 0.04 0.3 ± 0.1  
+6  11.1 ± 1.4  10.5 ± 1.4 0.2 ± 0.1  0.4 ± 0.1  
+8  13.0 ± 2.9 12.0 ± 2.9  0.5 ± 0.1  0.5 ± 0.1  
+24 9.7 ± 2.7  7.1 ± 2.6  0.6 ± 0.1 1.7 ± 0.3 

Data shown are mean ± SEM. Values refer to number of cells ×103/μL. Time points refer to intravenous LPS injection (t = 0). LPS, lipopolysaccharide.

Close Modal

or Create an Account

Close Modal
Close Modal